Skip to content
Screener

Medtronic MDT Q4 2026 Annual earnings

Reported June 3, 2026 · Before market open

Revenue$9.8BBeat by $192.1M
EPS$0.96Miss by $0.58
Revenue estimate$9.6B
EPS estimate$1.54
“Our performance reflects the strongest annual top-line growth Medtronic has delivered in 10 years, powered by disciplined execution across our portfolio and continued operational rigor, These results represent the compounding impact of deliberate choices we’ve made to strengthen our strategy, sharpen execution, and invest in the areas that will drive our future. We saw continued strength in some of our largest businesses like CRM, CST and Surgical, and we are building momentum in our highest growth opportunities, such as Affera, Symplicity, Hugo, Altaviva and Stealth AXiS. Together with the investments we’re making in our pipeline, Medtronic is well positioned to deliver sustained growth and long-term value.”
Geoff Martha

Next report

Sep 1, 2026 (In 4 days)
Revenue estimate$9.5B
EPS estimate$1.39

Financials

Q4 2026

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation & ratios

Valuation

as of 08/27/26
See full
Market cap$117.78B-0.2%
Enterprise value$145.04B-0.3%
P/E24.5×-0.8×
P/S3.2×-0.2×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp
FCF margin14.9%-0.5pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Segments

By segment

See full
Cardiovascular$3.8B+13.8%
Neuroscience$2.8B+5.0%
Medical Surgical$2.4B+8.0%
Diabetes$838.0M+15.1%
Other Operating Segments$33.8M—

FAQ

When did Medtronic report Q4 2026 earnings?
Medtronic (MDT) reported Q4 2026 earnings on June 3, 2026 before market open.
What were Medtronic's Q4 2026 revenue and EPS?
Medtronic reported revenue of $9.8B and eps of $0.96 for Q4 2026.
Did Medtronic beat estimates in Q4 2026?
Revenue beat the consensus estimate of $9.6B by $192.1M. EPS missed the consensus estimate of $1.54 by $0.58.
How did Medtronic's Q4 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.9% from $8.9B a year earlier and eps declined 40.7% from $1.62.
Where can I find Medtronic's Q4 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-040034) and the 10-K periodic report (0001628280-26-044354) directly on SEC EDGAR. The filing index links above go to sec.gov.